Patents by Inventor David Jay Julius

David Jay Julius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of identifying agents that modulate P2Y12 receptor activity
    Patent number: 6762029
    Abstract: The present invention includes a novel subtype of the P2-purinergic receptor, referred to as the P2Y12 receptor. This receptor is expressed selectively in the platelets and brain, and couples to a pertussis toxin-sensitive G protein (Gi). Nucleic acids encoding the receptor and associated screening and therapeutic methods are also disclosed.
    Type: Grant
    Filed: December 26, 2000
    Date of Patent: July 13, 2004
    Assignee: Portola Pharmaceuticals, Inc.
    Inventors: Pamela B. Conley, Hans-Michael Jantzen, Vanitha Ramakrishnan-DuBridge, David Jay Julius, Gunther Hollopeter
  • P2Y12 receptor
    Publication number: 20030170777
    Abstract: The present invention includes a novel subtype of the P2-purinergic receptor, referred to as the P2Y12 receptor. This receptor is expressed selectively in the platelets and brain, and couples to a pertussis toxin-sensitive G protein (Gi). Nucleic acids encoding the receptor and associated screening and therapeutic methods are also disclosed.
    Type: Application
    Filed: December 26, 2000
    Publication date: September 11, 2003
    Inventors: Pamela B. Conley, Hans-Michael Jantzen, Vanitha Ramakrishnan-DuBridge, David Jay Julius, Gunther Hollopeter